Bristol Myers’ pivotal year; Should AI be swinging bigger?; and morenews2026-05-02T10:00:47+00:00May 2nd, 2026|Endpoints News|
Moderna in talks with FDA over Phase 4 Covid vaccine datanews2026-05-01T18:08:48+00:00May 1st, 2026|Endpoints News|
FDA approves Pfizer and Arvinas’ breast cancer drug despite underwhelming datanews2026-05-01T17:33:49+00:00May 1st, 2026|Endpoints News|
Amgen launches late-stage obesity trial in patients who switch from rival drugsnews2026-05-01T17:23:32+00:00May 1st, 2026|Endpoints News|
Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS researchnews2026-05-01T16:50:12+00:00May 1st, 2026|Endpoints News|
Samsung Biologics workers begin five-day strike over wage disputes news2026-05-01T16:13:17+00:00May 1st, 2026|Endpoints News|
Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from Chinanews2026-05-01T15:27:46+00:00May 1st, 2026|Endpoints News|
Save the date: Premium subscriber-exclusive Post-Hoc Livenews2026-05-01T15:23:08+00:00May 1st, 2026|Endpoints News|
FDA approval for Alzheimer’s agitation drug; Esperion goes private in $1.1B dealnews2026-05-01T15:07:21+00:00May 1st, 2026|Endpoints News|
Summit slips on ivonescimab’s apparent interim miss in sign of investor frustrationnews2026-05-01T13:10:55+00:00May 1st, 2026|Endpoints News|
